Thanks to our generous match funders our campaign target has been achieved but the campaign continues… So far we have raised £365,334 and our new target is to raise £1million for a dedicated laboratory for research into neuroendocrine cancer at the Royal Free Hospital. We thank Ronny Allan for his efforts in raising awareness of our campaign.
For many people living with neuroendocrine tumours (NETs), the progression of the cancer is slow but for some people it presents aggressively–it may grow rapidly and spread to other parts of the body, causing a range of debilitating symptoms. Clinicians are yet to understand how people develop NETs, and why they present so aggressively in some and why tumours change their cell structure. Research in this area is chronically underfunded, and further study is urgently needed to improve treatment.
The Royal Free London houses the globally renowned neuroendocrine tumour (NET) research unit led by world-leading specialist Professor Martyn Caplin. Professor Caplin will use genomic profiling to research the impact of the heterogeneity of NETs on treatment efficacy, exploring why some cells within a patient are more aggressive, and why they change their structure and respond to treatment. This will speed up the prediction of treatment efficacy and facilitate the development of new therapies.